Page last updated: 2024-08-17

thymidine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

thymidine has been researched along with (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Armour, CL; Brown, KF; Foe, K; Hughes, JM; Jayrams, S; Mason, RS; Namkung-Matthai, H; Seale, JP; Seeto, C1

Other Studies

1 other study(ies) available for thymidine and (9R)-9-chloro-11,17-dihydroxy-17-(2-hydroxy-1-oxoethyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one

ArticleYear
Differential potency of beclomethasone esters in-vitro on human T-lymphocyte cytokine production and osteoblast activity.
    The Journal of pharmacy and pharmacology, 2000, Volume: 52, Issue:4

    Topics: Administration, Topical; Alkaline Phosphatase; Anti-Inflammatory Agents; Beclomethasone; Cytokines; Dexamethasone; Dose-Response Relationship, Drug; Esters; Glucocorticoids; Humans; Interleukin-5; Osteoblasts; Osteocalcin; T-Lymphocytes; Thymidine

2000